The Spiral Flow inducer in the Spiral Flow™ Peripheral Stent design aims to:
- Increase long term patency.
- Decrease neointimal hyperplasia.
- Reduce junctional zone restenosis.
- Reduce overall disease progression.
The majority of treatment modalities currently available to clinicians to treat peripheral arterial disease act as vessel liners and have no direct impact on the blood flow.
In August 2022, Vascular Flow were granted a European Patent for a Peripheral Stent with Spiral Flow Technology. This follows on from the USA patent issued in Aug 2021.
Vascular Flow intend to commercialise this technology through strategic commercial partnerships. By combining our unique, patented technology with current market leading devices we will deliver the best possible patient treatments for peripheral arterial disease.
Spiral Flow™ Peripheral Stent with Spiral Flow Technology